2-amino-5-phosphonovalerate has been researched along with Hashimoto Disease in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
Hashimoto Disease: Chronic autoimmune thyroiditis, characterized by the presence of high serum thyroid AUTOANTIBODIES; GOITER; and HYPOTHYROIDISM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koch, H | 1 |
| Niturad, CE | 1 |
| Theiss, S | 1 |
| Bien, CG | 1 |
| Elger, C | 1 |
| Wandinger, KP | 1 |
| Vincent, A | 1 |
| Malter, M | 1 |
| Körtvelyessy, P | 1 |
| Lerche, H | 1 |
| Dihné, M | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Hashimoto Disease
| Article | Year |
|---|---|
In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Cerebrospinal | 2019 |